MD Michael Hodges

October 17, 2021

MD Michael Hodges

Michael Hodges has deep RNA therapeutics technical expertise. He is supporting a number of Biotechnology companies in the role of drug development consultant.  Previously, he was the CMO of Amplyx Pharma, developing treatments for life-threatening viral and fungal infections in immuno-compromised patients.